Clinical Trial Update: Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy [Phase 3]

View source ↗

Summary

This Phase 3 trial assesses regorafenib versus placebo in Asian patients with metastatic colorectal cancer after standard therapy failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: Bayer | Conditions: Colorectal Neoplasms | Phase 3 | Status: COMPLETED